Market-Moving News for September 14th
Portfolio Pulse from ryanfaloona@benzinga.com
Nauticus Robotics has announced an offshore service agreement with Shell, causing KITT's stock to rise by 34%. First Wave BioPharma has announced an exclusive global license agreement for Capeserod from Sanofi, leading to a 100% increase in FWBI's stock. OKYO Pharma has announced a public offering of ordinary shares, resulting in a 34% decrease in OKYO's stock.
September 14, 2023 | 12:35 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
OKYO Pharma's public offering of ordinary shares has led to a 34% decrease in OKYO's stock.
OKYO Pharma's public offering of ordinary shares has increased the supply of shares in the market, leading to a decrease in OKYO's stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
First Wave BioPharma's exclusive global license agreement for Capeserod from Sanofi has led to a 100% increase in FWBI's stock.
The exclusive global license agreement for Capeserod from Sanofi is a significant deal for First Wave BioPharma, which has led to a doubling of FWBI's stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Nauticus Robotics' offshore service agreement with Shell has led to a 34% increase in KITT's stock.
The offshore service agreement between Nauticus Robotics and Shell is a significant partnership that has positively impacted KITT's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100